Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 4782820, 16 pages
https://doi.org/10.1155/2017/4782820
Research Article

The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury

The Jiangsu Key Laboratory of Neuroregeneration, Nantong University, 19 Qixiu Road, Nantong 226001, China

Correspondence should be addressed to Meijuan Yan; nc.ude.utn@zmy

Received 11 March 2017; Accepted 30 May 2017; Published 14 August 2017

Academic Editor: Hailiang Tang

Copyright © 2017 Yongqi Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Feeney, C. D. Johnston, R. Govender, J. O’Mahony, A. Coffey, and R. D. Sleator, “Analysis of the role of the Cronobacter sakazakii ProP homologues in osmotolerance,” Gut Pathogens, vol. 6, p. 15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Wang, Z. Zhong Chong, Y. Chen Shang, and K. Maiese, “WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1,” Current Neurovascular Research, vol. 10, no. 1, pp. 54–69, 2013. View at Google Scholar
  3. K. Venkatachalam, B. Venkatesan, A. J. Valente et al., “WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death,” The Journal of Biological Chemistry, vol. 284, no. 21, pp. 14414–14427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Wang, Z. Zhong Chong, Y. Chen Shang, and K. Maiese, “WISP1 (CCN4) autoregulates its expression and nuclear trafficking of beta-catenin during oxidant stress with limited effects upon neuronal autophagy,” Current Neurovascular Research, vol. 9, no. 2, pp. 91–101, 2012. View at Google Scholar
  5. D. Pennica, T. A. Swanson, J. W. Welsh et al., “WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt1-transformed cells and aberrantly expressed in human colon tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14717–14722, 1998. View at Google Scholar
  6. T. Doerks, R. R. Copley, J. Schultz, C. P. Ponting, and P. Bork, “Systematic identification of novel protein domain families associated with nuclear functions,” Genome Research, vol. 12, no. 1, pp. 47–56, 2002. View at Google Scholar
  7. J. T. Colston, S. D. de la Rosa, M. Koehler et al., “Wnt1-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor,” American Journal of Physiology Heart and Circulatory Physiology, vol. 293, no. 3, pp. H1839–H1846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. H. Hou, Y. C. Chiang, Y. C. Fong, and C. H. Tang, “WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells,” Biochemical Pharmacology, vol. 81, no. 11, pp. 1286–1295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Heise, V. Stober, C. Cheluvaraju, J. W. Hollingsworth, and S. Garantziotis, “Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity,” The Journal of Biological Chemistry, vol. 286, no. 20, pp. 17435–17444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. French, R. J. Kaul, A. L. D'Souza et al., “WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair,” The American Journal of Pathology, vol. 165, no. 3, pp. 855–867, 2004. View at Publisher · View at Google Scholar
  11. H. Kohara and Y. Tabata, “Enhancement of ectopic osteoid formation following the dual release of bone morphogenetic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges,” Biomaterials, vol. 32, no. 24, pp. 5726–5732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Wang, Z. Zhong Chong, Y. Chen Shang, and K. Maiese, “Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/AKT1 and apoptotic mitochondrial signaling involving bad, Bax, Bim, and Bcl-xL,” Current Neurovascular Research, vol. 9, no. 1, pp. 20–31, 2012. View at Google Scholar
  13. C. Nusslein-Volhard and E. Wieschaus, “Mutations affecting segment number and polarity in Drosophila,” Nature, vol. 287, no. 5785, pp. 795–801, 1980. View at Google Scholar
  14. P. D. McCrea, C. W. Turck, and B. Gumbiner, “A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin,” Science, vol. 254, no. 5036, pp. 1359–1361, 1991. View at Google Scholar
  15. W. I. Weis and W. J. Nelson, “Re-solving the cadherin-catenin-actin conundrum,” The Journal of Biological Chemistry, vol. 281, no. 47, pp. 35593–35597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Klaus and W. Birchmeier, “Wnt1 signalling and its impact on development and cancer,” Nature Reviews Cancer, vol. 8, no. 5, pp. 387–398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. O. M. Lucero, D. W. Dawson, R. T. Moon, and A. J. Chien, “A re-evaluation of the “oncogenic” nature of Wnt1/beta-catenin signaling in melanoma and other cancers,” Current Oncology Reports, vol. 12, no. 5, pp. 314–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Xu, R. B. Corcoran, J. W. Welsh, D. Pennica, and A. J. Levine, “WISP-1 is a Wnt1-1- and beta-catenin-responsive oncogene,” Genes & Development, vol. 14, no. 5, pp. 585–595, 2000. View at Google Scholar
  19. T. M. Nguyen, I. V. Subramanian, X. Xiao et al., “Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9B, pp. 3687–3698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Wang, L. Ding, X. Wang et al., “Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells,” American Journal of Translational Research, vol. 4, no. 1, pp. 44–51, 2012. View at Google Scholar
  21. T. Kasahara and T. Kato, “Nutritional biochemistry: a new redox-cofactor vitamin for mammals,” Nature, vol. 422, no. 6934, p. 832, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Q. Zhu, H. Z. Zhou, J. R. Teerlink, and J. S. Karliner, “Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion,” Cardiovascular Drugs and Therapy, vol. 18, no. 6, pp. 421–431, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Killgore, C. Smidt, L. Duich, N. Romero-Chapman, and D. Tinker, “Nutritional importance of pyrroloquinoline quinone,” Science, vol. 245, no. 4920, pp. 850–852, 1989. View at Google Scholar
  24. S. R. Datta, A. Brunet, and M. E. Greenberg, “Cellular survival: a play in three AKTs,” Genes & Development, vol. 13, no. 22, pp. 2905–2927, 1999. View at Google Scholar
  25. M. Halperin-Sheinfeld, A. Gertler, E. Okun, B. Sredni, and H. Y. Cohen, “The tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes,” Aging (Albany NY), vol. 4, no. 6, pp. 436–447, 2012. View at Publisher · View at Google Scholar
  26. I. L. Cabezas, A. Herrera Batista, and G. Pentón Rol, “The role of glial cells in Alzheimer disease: potential therapeutic implications,” Neurología, vol. 29, no. 5, pp. 305–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. K. Young, “Anatomical relationship between specialized astrocytes and leptin-sensitive neurones,” Journal of Anatomy, vol. 201, no. 1, pp. 85–90, 2002. View at Google Scholar
  28. E. Yamada and R. Singh, “Mapping autophagy on to your metabolic radar,” Diabetes, vol. 61, no. 2, pp. 272–280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Raghupathi, “Cell death mechanisms following traumatic brain injury,” Brain Pathology, vol. 14, no. 2, pp. 215–222, 2004. View at Google Scholar
  30. D. C. Rubinsztein, M. DiFiglia, N. Heintz et al., “Autophagy and its possible roles in nervous system diseases, damage and repair,” Autophagy, vol. 1, no. 1, pp. 11–22, 2005. View at Google Scholar
  31. M. Broe, C. E. Shepherd, E. A. Milward, and G. M. Halliday, “Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer’s disease and dementia with Lewy bodies,” Acta Neuropathologica, vol. 101, no. 6, pp. 616–624, 2001. View at Google Scholar
  32. N. Louneva, J. W. Cohen, L. Y. Han et al., “Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer’s disease,” The American Journal of Pathology, vol. 173, no. 5, pp. 1488–1495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Maiese, F. Li, Z. Z. Chong, and Y. C. Shang, “The Wnt1 signaling pathway: aging gracefully as a protectionist?” Pharmacology & Therapeutics, vol. 118, no. 1, pp. 58–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Venkatesan, S. D. Prabhu, K. Venkatachalam et al., “Wnt1 inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death,” Cellular Signalling, vol. 22, no. 5, pp. 809–820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. K. He, H. Nukada, T. Urakami, and M. P. Murphy, “Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems,” Biochemical Pharmacology, vol. 65, no. 1, pp. 67–74, 2003. View at Google Scholar
  36. Y. Zhang, P. J. Feustel, and H. K. Kimelberg, “Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat,” Brain Research, vol. 1094, no. 1, pp. 200–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. M. Sanchez, C. Wang, G. Gardner et al., “Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures,” The Journal of Neuroscience, vol. 20, no. 6, pp. 2409–2417, 2000. View at Google Scholar